CVMP guidance adopted in January now available online

3 February, 2016

The guidance documents adopted by the CVMP in their January meeting have now been published on the EMA website:

  • Draft guideline on efficacy and target animal safety data requirements for veterinary medicinal products intended for minor use or minor species (MUMS)/limited market (Link)
  • Draft guideline on safety and residue data requirements for veterinary medicinal products intended for minor use or minor species (MUMS)/limited market (Link)
  • Draft guideline on quality data requirements for veterinary medicinal products intended for minor use or minor species (MUMS)/limited market (Link)
  • Draft guideline on data requirements for immunological veterinary medicinal products intended for minor use or minor species (MUMS)/limited market (Link)
  • Guideline for the demonstration of efficacy for veterinary medicinal products containing antimicrobial substances (Link). An overview of comments received during the consultation is also available (Link)
  • Concept paper for the revision on the guideline for the conduct of pharmacokinetic studies in target animal species (Link)
Business Units: 

Regulatory Outsourcing Options

Cyton’s dedicated regulatory procedures team can support you with:
 - Dossier preparation, submission & regulatory procedures
 - Regulatory intelligence and strategic planning
 - Life cycle management
 - Key person cover
 - Pharmacovigilance
 - Brexit support services